Journals - All Articles

Changing rooms act as critical control points within pharmaceutical manufacturing facilities, functioning as microbial airlocks that limit personnel‑borne contamination entering classified processing areas. This study presents a five‑year comparative analysis (2022–2025) of microorganisms recovered from changing rooms and adjacent corridors, spanning cleanroom Grades D, C, and B.

Review of Developments in GMP and the Regulation of Medicines January 2026  EJPPS Volume 31.1A INTRODUCTION The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) • UK and Singapore launch a regulatory innovation corridor to speed up access to breakthrough health technologies • Strengthening collaboration between the MHRA and the Department of Health Northern Ireland • Updated guidance on the Health Institutio

Review of Developments in GMP and the Regulation of Medicines March 2026 EJPPS Volume 31.1C INTRODUCTION During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the UK, EU, USA Swiss & PIC/S regulatory authorities. The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) MHRA Guest Blog- Mila to Millions (by Juli